YAP-1: Immunotherapy Efficacy in ES-SCLC Patients
In extensive-stage small-cell lung cancer (ES-SCLC), IMpower133 improved progression-free survival...
Read More
Author: Rahul Sharma
Low-Dose Radiotherapy Plus Atezolizumab & Chemotherapy Benefits ES-SCLC
Researchers conducted the MATCH study to assess the clinical benefits of adding low-dose...
Read More
ES-SCLC: Anti-PD-L1 Blockades With Etoposide & Platinum
According to IMpower133 and CASPIAN, anti-PD-L1 blockades combined with etoposide and platinum...
Read More
Neoadjuvant Immunotherapy for Advanced, Resectable CSCC-HN
Researchers studied neoadjuvant immunotherapy to produce a pathologic response in patients with...
Read More
Usage of Immunotherapy in Merkel Cell Carcinoma
Merkel Cell Carcinoma (MCC) was rare, and aggressive skin cancer became more common as the...
Read More
Treatment Resistant HPV+ Head & Neck Squamous Cell Carcinoma
Cancer’s biological behavior was exceedingly complex, driven by the nonlinear interplay of...
Read More
Age Associated Mutation in Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinoma was the most frequent type of skin cancer globally. The presence...
Read More
Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
In the United States, almost 1.5 million cutaneous squamous cell cancer (cSCC) are identified...
Read More
CLL: Acalabrutinib ± Obinutuzumab Vs Obinutuzumab + Chlorambucil
Researchers previously demonstrated improved efficacy of acalabrutinib (A) obinutuzumab (O) vs. O...
Read More
R/R CLL: Acalabrutinib Vs Rituximab With Idelalisib or Bendamustine
Acalabrutinib (Acala) was a next-generation, highly selective, covalent Bruton tyrosine kinase...
Read More
SEER Program Data: Chronic Lymphocytic Leukemia Patients
Over the last 2 decades, treatment for chronic lymphocytic leukemia (CLL) has evolved...
Read More
Reduced Disease Progression With Ublituximab vs Teriflunomide in MS
Ublituximab is a new monoclonal antibody that targets a specific epitope on the antigen CD20....
Read More
Poor Prognosis With Cachexia After First-Line Immunotherapy for ES-SCLC
To analyze the link between cachexia and prognosis among patients with extensive-stage small-cell...
Read MoreChronic Lymphocytic Leukemia Treated at Academic Centers
For a study, researchers sought to see if patients with chronic lymphocytic leukemia (CLL) who were treated at Commission on Cancer accredited academic centers (ACs), which had a high clinical volume, access to clinical trials,...
Read More
Psychological Mobile App for Acute Myeloid Leukemia (AML) Patients
During their hospitalization for rigorous chemotherapy, patients with Acute Myeloid Leukemia (AML)...
Read MoreFrailty Increases Morbidity & Mortality in Elderly Patients With Burns
Frailty negatively impacted morbidity, mortality, and healthcare utilization in elderly patients with burns, according to findings published in the Journal of Burn Care & Research. Kathleen A. Iles, MD, and colleagues used...
Read MoreCold-Induced Anaphylaxis Frequent in Patients With Cold Urticaria
Cold-induced anaphylaxis (ColdA) was common in patients with typical cold urticaria (ColdU), according to findings published in Allergy. Researchers performed an international, cross-sectional study at 32 urticaria centers,...
Read MoreAllergy History May Increase Risk for mRNA COVID-19 Vaccine Reaction
Self-reported history of high-risk allergy is associated with a greater risk for self-reported allergic reactions within 3 days of mRNA COVID-19 vaccination among healthcare workers, according to a study published in JAMA...
Read MoreTelerehabilitation for COPD Is Safe & Achieves Meaningful Benefits
Telerehabilitation is safe and achieves clinically meaningful benefits, according to a study published in Thorax. Narelle S. Cox, Ph.D., and colleagues investigated whether home-based telerehabilitation was equivalent to...
Read More6MWT Bests VO2max as Cardiorespiratory Fitness Measure
Cardiorespiratory fitness (CRF) classification by the 6-minute walk test (6MWT) distance is valid in comparison with VO2max, especially for identifying adults with low CRF, according to a study published in Pulmonology. Victor...
Read More- 1
- 2